Peak Financial Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$384K Buy
+320
New +$327K 0.09% 68
2026
Q1
Sell
-291
Closed -$313K 102
2025
Q4
$313K Sell
291
-25
-8% -$23.9K 0.08% 74
2025
Q3
$241K Buy
316
+30
+10% +$22.3K 0.06% 84
2025
Q2
$223K Sell
286
-34
-11% -$26.4K 0.06% 89
2025
Q1
$264K Sell
320
-45
-12% -$37.4K 0.08% 76
2024
Q4
$282K Buy
365
+136
+59% +$113K 0.08% 77
2024
Q3
$203K Sell
229
-189
-45% -$170K 0.06% 98
2024
Q2
$378K Sell
418
-235
-36% -$188K 0.12% 68
2024
Q1
$508K Buy
653
+263
+67% +$187K 0.16% 54
2023
Q4
$227K Buy
+390
New +$228K 0.08% 79
2023
Q3
Sell
-584
Closed -$274K 75
2023
Q2
$274K Buy
+584
New +$245K 0.1% 71

Other funds holding LLY

Peak Financial Management's LLY Position: Q2 2026 in Review

Peak Financial Management opened a new position in Eli Lilly (LLY) in Q2 2026: 320 shares worth $384K. The stake represents 0.09% of the portfolio and ranks #68 among its holdings. This is a return to the name: Peak Financial Management previously reported a position in LLY as recently as Q4 2025.

Peak Financial Management first reported a position in LLY in Q2 2023 and has held it in 11 quarters since. The position peaked at $508K in Q1 2024. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Peak Financial Management held 320 shares of Eli Lilly worth $384K as of Q2 2026.
  • Eli Lilly was a new Peak Financial Management position in Q2 2026.
  • Eli Lilly made up 0.09% of Peak Financial Management's portfolio in Q2 2026, its #68 holding.
  • Peak Financial Management first reported a position in Eli Lilly in Q2 2023 and has held it in 11 quarters since.
  • Peak Financial Management's Eli Lilly position peaked at $508K in Q1 2024.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Peak Financial Management's 13F filing for Q2 2026, filed 20 Jul 2026.